| Hazardous effects of chemical pesticides on human health–Cancer and other associated disorders A Sabarwal, K Kumar, RP Singh Environmental toxicology and pharmacology 63, 103-114, 2018 | 612 | 2018 |
| Metabolic reprogramming in renal cancer: events of a metabolic disease S Chakraborty, M Balan, A Sabarwal, TK Choueiri, S Pal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (1), 188559, 2021 | 95 | 2021 |
| Fisetin inhibits cellular proliferation and induces mitochondria‐dependent apoptosis in human gastric cancer cells A Sabarwal, R Agarwal, RP Singh Molecular carcinogenesis 56 (2), 499-514, 2017 | 80 | 2017 |
| Mancozeb selectively induces mitochondrial-mediated apoptosis in human gastric carcinoma cells through ROS generation K Kumar, A Sabarwal, RP Singh Mitochondrion 48, 1-10, 2019 | 45 | 2019 |
| Lupeol induces S-phase arrest and mitochondria-mediated apoptosis in cervical cancer cells N Prasad, A Sabarwal, UCS Yadav, RP Singh Journal of biosciences 43, 249-261, 2018 | 41 | 2018 |
| Plumbagin induces ROS-mediated apoptosis and cell cycle arrest and inhibits EMT in human cervical carcinoma cells A Jaiswal, A Sabarwal, JPN Mishra, RP Singh RSC advances 8 (56), 32022-32037, 2018 | 38 | 2018 |
| Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down-regulation of Akt J Tak, A Sabarwal, RK Shyanti, RP Singh Molecular and Cellular Biochemistry 458, 49-59, 2019 | 28 | 2019 |
| A novel combination treatment with Honokiol and Rapamycin effectively restricts c-Met-induced growth of renal cancer cells, and also inhibits the expression of tumor Cell PD-L1 … A Sabarwal, S Chakraborty, S Mahanta, S Banerjee, M Balan, S Pal Cancers 12 (7), 1782, 2020 | 15 | 2020 |
| Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells Y Hamedani, S Chakraborty, A Sabarwal, S Pal, S Bhowmick, M Balan PLoS One 15 (12), e0243837, 2020 | 13 | 2020 |
| A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress L Rawat, M Balan, Y Sasamoto, A Sabarwal, S Pal Redox biology 68, 102945, 2023 | 8 | 2023 |
| Aminoacyl‐tRNA synthetase–a molecular multitasker S Gupta, J Jani, Vijayasurya, J Mochi, S Tabasum, A Sabarwal, ... The FASEB Journal 37 (11), e23219, 2023 | 8 | 2023 |
| A novel 4′‐brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non‐small‐cell lung cancer without any adverse … A Sabarwal, JC van Rooyen, J Caburet, M Avgenikos, A Dheeraj, M Ali, ... The FASEB Journal 36 (12), e22654, 2022 | 8 | 2022 |
| A combination therapy using an mTOR inhibitor and honokiol effectively induces autophagy through the modulation of AXL and rubicon in renal cancer cells and restricts renal … A Sabarwal, J Wedel, K Liu, D Zurakowski, S Chakraborty, E Flynn, ... Carcinogenesis 43 (4), 360-370, 2022 | 8 | 2022 |
| Curcumin in Cancer Prevention A Sabarwal, K Kumar, R Shyanti, RP Singh Functional Food and Human Health, 329-374, 2018 | 4 | 2018 |
| The Biology of Aging and Cancer: A complex Association M Rajput, L Dwivedi, A Sabarwal, RP Singh Models, Molecules and Mechanisms in Biogerontology, 465-497, 2020 | 1 | 2020 |
| 49 Inhibition of AXL along with c-Met potentially halts resistance development in renal cell carcinoma M Machaalani, A Sabarwal, L Rawat, M Balan, M Eid, E Saad, K Semaan, ... The Oncologist 29 (Supplement_1), S27-S28, 2024 | | 2024 |
| Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy R Kumar, H Goel, R Solanki, L Rawat, S Tabasum, P Tanwar, S Pal, ... Medicine in drug discovery, 100195, 2024 | | 2024 |
| c-Met/AXL crosstalk in mediating therapeutic resistance in renal cell carcinoma A Sabarwal, L Rawat, J Wedel, M Balan, GSM Lee, TK Choueiri, S Pal Cancer Research 84 (6_Supplement), 4555-4555, 2024 | | 2024 |
| 4'-substituted analogues of fisetin and their use in the treatment of cancer CH Kaschula, RP Singh, A Dheeraj, A Sabarwal US Patent App. 18/039,397, 2024 | | 2024 |
| Targeting AXL can effectively inhibit c-Met-induced therapeutic resistance in renal cancer A Sabarwal, L Rawat, J Wedel, Y Sasamoto, S Signoretti, TK Choueiri, ... Cancer Research 83 (7_Supplement), 3866-3866, 2023 | | 2023 |
Rana P SinghProfessor, School of Life Sciences, Jawaharlal Nehru UniversityVerified email at mail.jnu.ac.in
